88 related articles for article (PubMed ID: 8331535)
21. Mode of administration-dependent pharmacokinetics of bisphosphonates and bioavailability determination.
Hoffman A; Stepensky D; Ezra A; Van Gelder JM; Golomb G
Int J Pharm; 2001 Jun; 220(1-2):1-11. PubMed ID: 11376962
[TBL] [Abstract][Full Text] [Related]
22. The pharmacokinetics and oral bioavailability studies of columbianetin in rats after oral and intravenous administration.
Luo Q; Wang CP; Li J; Ma WF; Bai Y; Ma L; Gao XM; Zhang BL; Chang YX
J Ethnopharmacol; 2013 Oct; 150(1):175-80. PubMed ID: 23994338
[TBL] [Abstract][Full Text] [Related]
23. Absorption and excretion of paeoniflorin in rats.
Takeda S; Isono T; Wakui Y; Matsuzaki Y; Sasaki H; Amagaya S; Maruno M
J Pharm Pharmacol; 1995 Dec; 47(12A):1036-40. PubMed ID: 8932691
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of DA-8159, a new erectogenic, after intravenous and oral administration to rats: hepatic and intestinal first-pass effects.
Shim HJ; Kim YC; Park KJ; Kim DS; Kwon JW; Kim WB; Lee MG
J Pharm Sci; 2003 Nov; 92(11):2185-95. PubMed ID: 14603504
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of valerenic acid in rats after intravenous and oral administrations.
Sampath C; Haug K; Thanei S; Hamburger M; Derendorf H; Frye R; Butterweck V
Planta Med; 2012 Apr; 78(6):575-81. PubMed ID: 22411722
[TBL] [Abstract][Full Text] [Related]
27. Analytical determination and pharmacokinetics of robenacoxib in the dog.
Jung M; Lees P; Seewald W; King JN
J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
[TBL] [Abstract][Full Text] [Related]
28. Influence of the route of administration on the pharmacokinetics of pirprofen enantiomers in the rat.
Brocks DR; Liang WT; Jamali F
Chirality; 1993; 5(2):61-4. PubMed ID: 8343343
[TBL] [Abstract][Full Text] [Related]
29. Single dose pharmacokinetics and bioavailability of glucosamine in the rat.
Aghazadeh-Habashi A; Sattari S; Pasutto F; Jamali F
J Pharm Pharm Sci; 2002; 5(2):181-4. PubMed ID: 12207871
[TBL] [Abstract][Full Text] [Related]
30. Oral and intravenous trichloroethylene pharmacokinetics in the rat.
D'Souza RW; Bruckner JV; Feldman S
J Toxicol Environ Health; 1985; 15(5):587-601. PubMed ID: 4046066
[TBL] [Abstract][Full Text] [Related]
31. Toxicokinetics and bioavailability of sulfolane, a ground water contaminant, following oral and intravenous administration in rodents: A dose, species, and sex comparison.
Waidyanatha S; Black SR; Fennell TR; Watson SL; Patel PR; Cooper SD; Blake J; Robinson VG; Fernando RA; Blystone CR
Toxicol Appl Pharmacol; 2019 Sep; 379():114690. PubMed ID: 31344372
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of a rat model versus a physiologically based extraction test for assessing phenanthrene bioavailability from soils.
Pu X; Lee LS; Galinsky RE; Carlson GP
Toxicol Sci; 2004 May; 79(1):10-7. PubMed ID: 14976340
[TBL] [Abstract][Full Text] [Related]
33. Gender-related pharmacokinetics and absolute bioavailability of diosbulbin B in rats determined by ultra-performance liquid chromatography-tandem mass spectrometry.
Yang B; Wang X; Liu W; Zhang Q; Chen K; Ma Y; Wang C; Wang Z
J Ethnopharmacol; 2013 Oct; 149(3):810-5. PubMed ID: 23954278
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of bioequivalence after oral, intramuscular, and intravenous administration of racemic ketoprofen in pigs.
Raekallio MR; Mustonen KM; Heinonen ML; Peltoniemi OA; Säkkinen MS; Peltoniemi SM; Honkavaara JM; Vainio OM
Am J Vet Res; 2008 Jan; 69(1):108-13. PubMed ID: 18167095
[TBL] [Abstract][Full Text] [Related]
35. Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers.
Taylor TJ; Diringer K; Russell T; Venkatakrishnan K; Wilner K; Crownover PH; Benincosa LJ; Gibbs MA
Clin Pharmacokinet; 2006; 45(10):989-1001. PubMed ID: 16984212
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics and bioavailability of the flavonoid 7,8-benzoflavone in rats.
Wang X; Morris ME
J Pharm Sci; 2008 Oct; 97(10):4546-56. PubMed ID: 18257033
[TBL] [Abstract][Full Text] [Related]
37. Preclinical pharmacokinetic evaluation of resveratrol trimethyl ether in sprague-dawley rats: the impacts of aqueous solubility, dose escalation, food and repeated dosing on oral bioavailability.
Lin HS; Ho PC
J Pharm Sci; 2011 Oct; 100(10):4491-500. PubMed ID: 21520090
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of E-6087, a new anti-inflammatory agent, in rats and dogs.
Reinoso RF; Farrán R; Moragón T; García-Soret A; Martínez L
Biopharm Drug Dispos; 2001 Sep; 22(6):231-42. PubMed ID: 11754039
[TBL] [Abstract][Full Text] [Related]
39. Determination of geniposide in adjuvant arthritis rat plasma by ultra-high performance liquid chromatography tandem mass spectrometry method and its application to oral bioavailability and plasma protein binding ability studies.
Chen J; Wu H; Xu GB; Dai MM; Hu SL; Sun LL; Wang W; Wang R; Li SP; Li GQ
J Pharm Biomed Anal; 2015 Apr; 108():122-8. PubMed ID: 25771205
[TBL] [Abstract][Full Text] [Related]
40. Comparative pharmacokinetics and bioavailability of tapentadol following oral administration of immediate- and prolonged-release formulations.
Göhler K; Brett M; Smit JW; Rengelshausen J; Terlinden R
Int J Clin Pharmacol Ther; 2013 Apr; 51(4):338-48. PubMed ID: 23357834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
